ertugliflozin pyroglutamic acid - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
STEGLUJAN 15/100 ertugliflozin/sitagliptin (as phosphate monohydrate) 15 mg/100 mg film-coated tablet blister pack AUST R: 287626Active ingredients:
ertugliflozin pyroglutamic acid
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
30 Jun 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|
STEGLUJAN 5/100 ertugliflozin/sitagliptin (as phosphate monohydrate) 5 mg/100 mg film-coated tablet blister pack AUST R: 287630Active ingredients:
ertugliflozin pyroglutamic acid
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
30 Jun 2023
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|